Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3765744016 | Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3765745015 | Betaxolol hydrochloride 2.5 mg/mL eye suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Plays role | Antiglaucoma therapeutic role | false | Inferred relationship | Some | ||
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has basis of strength substance (attribute) | Betaxolol hydrochloride (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has precise active ingredient | Betaxolol hydrochloride (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | est un(e) (attribut) | Betaxolol only product in ocular dose form | false | Inferred relationship | Some | ||
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | a une forme pharmaceutique (attribut) | Eye suspension | false | Inferred relationship | Some | ||
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength numerator value (attribute) | 2.5 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Product containing precisely betaxolol hydrochloride 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) | Has concentration strength denominator unit | Milliliter (qualifier value) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR